| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |